Evidence map›Paper›PMID 23349930›Full record

ArticlePloS one2013

Effector protein translocation by the Coxiella burnetii Dot/Icm type IV secretion system requires endocytic maturation of the pathogen-occupied vacuole.

Hayley J Newton, Justin A McDonough, Craig R Roy

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed
9.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 141 citations in OpenAlex.

  1. Article
  2. Quantitative three-dimensional imaging ofInfection and immunity · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. TFEB and MCOLN1 are important forFrontiers in cellular and infection microbiology · 2026
    Article
  8. Bacterial Puppeteering: How the Stealth BacteriumPathogens (Basel, Switzerland) · 2025
    Review
  9. Article
  10. Identification of aInfection and immunity · 2025
    Article
  11. Experimental Approaches to Visualize Effector Protein Translocation During Host-Pathogen Interactions.BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
  12. Acid Tolerance ofPathogens (Basel, Switzerland) · 2025
    Article
  13. Review
  14. Frontiers in immunology · 2025
    Article
  15. Article
  16. Journal of bacteriology · 2024
    Article
  17. Article
  18. Review
  19. Article
  20. Caspase-8 activity mediates TNFα production and restrictsbioRxiv : the preprint server for biology · 2024
    Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Hayley J NewtonDepartment of Microbial Pathogenesis, Yale University School of Medicine, New Haven, Connecticut, USA. hayley.newton@yale.edu
Justin A McDonough
Craig R Roy
Yale University · US

Funding

Viral Pathogenesis and TherapeuticsU54AI057158 · NIAID · WADSWORTH CENTER · PI LEVY, DAVID E · 2003 to 2014
$100.8M
Modulation of Host Cell Functions by Coxiella burnetiiR01AI064559 · NIAID · YALE UNIVERSITY · PI ROY, CRAIG R. · 2006 to 2010
$1.8M
NIAID NIH HHS F32-AI0829272NIAID NIH HHS R01 AI064559NIAID NIH HHS R01-AI064559NIAID NIH HHS U54 AI057158NIAID NIH HHS U54-AI057158
6 · The paper itself

Abstract

The human pathogen Coxiella burnetii encodes a type IV secretion system called Dot/Icm that is essential for intracellular replication. The Dot/Icm system delivers bacterial effector proteins into the host cytosol during infection. The effector proteins delivered by C. burnetii are predicted to have important functions during infection, but when these proteins are needed during infection has not been clearly defined. Here, we use a reporter system consisting of fusion proteins that have a β-lactamase enzyme (BlaM) fused to C. burnetii effector proteins to study protein translocation by the Dot/Icm system. Translocation of BlaM fused to the effector proteins CBU0077, CBU1823 and CBU1524 was not detected until 8-hours after infection of HeLa cells, which are permissive for C. burnetii replication. Translocation of these effector fusion proteins by the Dot/Icm system required acidification of the Coxiella-containing vacuole. Silencing of the host genes encoding the membrane transport regulators Rab5 or Rab7 interfered with effector translocation, which indicates that effectors are not translocated until bacteria traffic to a late endocytic compartment in the host cell. Similar requirements for effector translocation were discerned in bone marrow macrophages derived from C57BL/6 mice, which are primary cells that restrict the intracellular replication of C. burnetii. In addition to requiring endocytic maturation of the vacuole for Dot/Icm-mediated translocation of effectors, bacterial transcription was required for this process. Thus, translocation of effector proteins by the C. burnetii Dot/Icm system occurs after acidification of the CCV and maturation of this specialized organelle to a late endocytic compartment. This indicates that creation of the specialized vacuole in which C. burnetii replicates represents a two-stage process mediated initially by host factors that regulate endocytic maturation and then by bacterial effectors delivered into host cells after bacteria establish residency in a lysosome-derived organelle.

Indexed as

AnimalsBacterial Secretion Systemsbeta-LactamasesCarrier ProteinsCoxiella burnetiiExtracellular MatrixHeLa CellsHost-Pathogen InteractionsHumansMembrane Transport ProteinsMiceMice, Inbred C57BLProtein TransportRecombinant Fusion ProteinsVacuolesBacterial Secretion Systemsbeta-LactamasesCarrier Proteinscitrate-binding transport proteinMembrane Transport ProteinsRecombinant Fusion Proteins

Identifiers

PMID23349930
PMCPMC3547880
OpenAlexW2056084424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.